Skip to content

Clinical trials

Scleroderma, Systemic trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Scleroderma, Systemic Country / region: Netherlands Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20112
20154
20172
20182
20202
20212
20221
20231
20242
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Recruiting3
Active, not recruiting2
Unknown status2
Not yet recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim4
Actelion3
UMC Utrecht3
AstraZeneca1
Bayer1
Bristol-Myers Squibb1
Certa Therapeutics1
Gesynta Pharma AB1
GlaxoSmithKline1
Hoffmann-La Roche1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Scleroderma, Systemic21
Scleroderma, Diffuse5
Autoimmune Diseases2
Lung Diseases, Interstitial2
Pulmonary Arterial Hypertension2
Arthritis, Rheumatoid1
Dermatomyositis1
Dry Eye Syndromes1
Hypertension, Pulmonary1
Immune System Diseases1

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.